Advanced Medical Solutions Group plc
AMS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.17 | -1.18 | -0.68 | -0.76 |
| FCF Yield | 2.70% | 1.46% | 1.19% | 1.41% |
| EV / EBITDA | 27.12 | 28.14 | 46.24 | 25.74 |
| Quality | ||||
| ROIC | 2.15% | 1.37% | 0.77% | 2.33% |
| Gross Margin | 53.49% | 44.87% | 54.27% | 54.64% |
| Cash Conversion Ratio | 2.44 | 3.00 | 1.67 | 1.18 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.61% | 17.10% | 9.79% | 6.92% |
| Free Cash Flow Growth | 100.17% | 17.95% | -15.63% | 2,184.34% |
| Safety | ||||
| Net Debt / EBITDA | 3.18 | 3.86 | -5.10 | -3.26 |
| Interest Coverage | 4.09 | 2.07 | 13.39 | 13.16 |
| Efficiency | ||||
| Inventory Turnover | 0.83 | 1.09 | 0.81 | 0.79 |
| Cash Conversion Cycle | 91.83 | 76.12 | 86.08 | 125.50 |